Search

Your search keyword '"Fratta, Mario"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Fratta, Mario" Remove constraint Author: "Fratta, Mario"
35 results on '"Fratta, Mario"'

Search Results

1. Hydranencephaly in CENPJ-related Seckel syndrome

3. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

4. Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study

6. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

7. Ocrelizumab treatment in multiple sclerosis: Prospective real world observational multi-center study in Campania, Italy

8. Identification of Covid-19 suspect cases through a digital triage: a multicenter Italian-Iranian study on

15. Expanding the spectrum of SPTLC1‐related disorders beyond hereditary sensory and autonomic neuropathies: A novel case of the distinct "S331 syndrome".

16. Rasagiline improves sleep disorders in Parkinson's disease

17. Delayed post‐hypoxic leukoencephalopathy with a peculiar autoantibody association.

18. Large cardio-embolic ischemic stroke in Kearns-Sayre syndrome

21. Serum Osteocalcin in 1634 Healthy Children

25. Modifications moleculaires au cours de la regeneration et reinnervation musculaires in vitro

26. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

27. Expanding the spectrum of <scp> SPTLC1 </scp> ‐related disorders beyond hereditary sensory and autonomic neuropathies: A novel case of the distinct ' <scp>S331</scp> syndrome'

28. Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study

29. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

30. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

31. A case of Foix–Chavany–Marie syndrome due to bilateral corona radiata infarcts

32. Delayed post‐hypoxic leukoencephalopathy with a peculiar autoantibody association

33. Lymphocytosis as a response biomarker of natalizumab therapeutic efficacy in multiple sclerosis

34. Multi-imaging study in a patient with cerebrotendinous xanthomatosis: radiology, clinic and pathology correlation of a rare condition.

35. Tumor necrosis factor-alpha and insulin-like growth factor-1 levels in patients with relapsing-remitting multiple sclerosis receiving interferon-beta1a.

Catalog

Books, media, physical & digital resources